Upcoming Themed Issues:
PSP Fourth Quarter 2025: Model-Based Innovations in Pediatric Rare Disease
CPT: Pharmacometrics and Systems Pharmacology (
PSP) inviting submissions for a special themed issue on Model-Based Innovations in Pediatric Rare Disease scheduled for publication in the 4th quarter of 2025. This special issue will showcase the application of pharmacometrics and systems pharmacology research innovation in the development of therapeutics and advances in understanding disease progression for pediatric rare diseases. Original research articles are encouraged. Submissions may also include reviews/mini-reviews, tutorials, position/white papers, PSP case reports, and perspectives from regulatory agencies, academia, societies, and industry.
Click here for more info.
To be considered for publication in this themed issue, manuscripts should be submitted via the online submission and tracking system by
May 15, 2025.
CPT December 2025: Innovations in Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics (
CPT) inviting submissions for a special themed issue on "Innovations in Clinical Pharmacology and Therapeutics," scheduled for publication in December 2025. This issue aims to showcase groundbreaking scientific advances and innovations that are shaping the field of clinical pharmacology and therapeutics. From emerging technologies to global regulatory approaches paving the way for transformative therapeutic innovations, the issue will highlight the diversity and interdisciplinary nature of innovation in clinical pharmacology. Submissions of original research are particularly encouraged, but reviews, position/white papers or shorter perspectives are also welcome. Educational, tutorial-style papers will also be considered. In the cover letter of your submission, please state that you are responding to this Call for Papers.
Click here for more info.
To be considered for publication in this themed issue, manuscripts should be submitted via the online submission and tracking system by
May 15, 2025.
PSP December 2025: Applications and Innovations in Model-Based Meta-Analysis (MBMA)
CPT: Pharmacometrics and Systems Pharmacology (
PSP) inviting submissions for a special mini-themed issue on Applications and Innovations in Model-Based Meta-Analysis (MBMA) scheduled for publication in December 2025. It is therefore essential to underscore the utilization of MBMA in general, as publications of MBMA are relatively scarce compared to, e.g., traditional pairwise meta-analysis or comparative network meta-analysis. This proposal calls for use cases of MBMA and exploration into future directions of MBMA from the broader clinical pharmacology community. Original research articles are encouraged. Submissions may also include reviews/mini-reviews, tutorials, position/white papers, PSP case reports, and perspectives from regulatory agencies, academia, societies, and industry.
Click here for more info.
To be considered for publication in this themed issue, manuscripts should be submitted via the online submission and tracking system by
June 15, 2025.
CTS: Biomarkers
Clinical and Translational Science (
CTS) inviting submissions for a special collection dedicated to identifying, assessing, validating, and utilizing biomarkers for drug development and clinical use. To highlight the potential of biomarkers we welcome original research articles, brief reports, mini-reviews, reviews, tutorials, perspectives, and position papers that explore or contribute to the field of biomarkers in drug development, translational science, and clinical pharmacology.
Click here for more info.
To be considered for publication in this themed issue, manuscripts should be submitted via the online submission and tracking system by
August 1, 2025.
CTS: Mechanism of Action Mini Reviews
Clinical and Translational Science (
CTS) is inviting submissions for a special collection on Mechanism of Action Mini Reviews.
CTS’s “Mechanism of Action Mini Reviews” demystify these complex agents and modalities, from mechanism to development and regulatory journey to clinical impact. For practitioners, pharmacists, and researchers, these mini reviews offer a concise yet comprehensive understanding of new therapeutics. For patients and the general public, they provide insights into how these drugs can manage or cure diseases, enhancing informed healthcare decisions.
Click here for more info.